H-1B & Green Card Sponsorship Data
Source: US Dept of Labor. Represents Base Salary only. Excludes RSUs, signing bonuses, and variable compensation. View All Salary RecordsTotal Filings
2021-PresentApproval Rate
Certified CasesMedian Salary
Across All Roles| Program | Last Filing | Dated filings (2021–Present) |
|---|---|---|
| H-1B | Apr 30, 2026 | 19 |
| E-3 | Jun 3, 2025 | 3 |
| PERM | Oct 25, 2024 | 4 |
| Role | Last Filing | Dated filings (2021–Present) |
|---|---|---|
| DIRECTOR, MARKET RESEARCH & COMPETITIVE INTELLIGEN | Apr 30, 2026 | 1 |
| Medical Director, Patient Safety & Pharmacovigilance | Apr 17, 2026 | 1 |
| Director, Field Operations & Data Management | Apr 17, 2026 | 1 |
| Clinical Trial Manager | Sep 18, 2025 | 4 |
| Principal Research Associate | Jun 23, 2025 | 5 |
| Role | Count | Median Salary | Min | Max |
|---|---|---|---|---|
| Principal Research Associate | 5 | $105,000 | $86,798 | $127,150 |
| Clinical Trial Manager | 4 | $162,346 | $161,371 | $165,296 |
| RESEARCH SCIENTIST I, MEDICINAL CHEMISTRY | 4 | $123,614 | $123,614 | $143,136 |
| Clinical Biomarker Scientist | 2 | $137,342 | $98,654 | $176,030 |
| Principal Research Scientist, Medicinal Chemistry | 2 | $158,988 | $152,984 | $164,991 |
| Director, Drug Safety Operations/Science and Compliance | 1 | $206,190 | $206,190 | $206,190 |
| Director, Field Operations & Data Management | 1 | $216,000 | $216,000 | $216,000 |
| DIRECTOR, MARKET RESEARCH & COMPETITIVE INTELLIGEN | 1 | $272,397 | $272,397 | $272,397 |
| Medical Director, Patient Safety & Pharmacovigilance | 1 | $268,000 | $268,000 | $268,000 |
| Principal Clinical Biomarker Scientist | 1 | $116,438 | $116,438 | $116,438 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 1 | $98,654 | 100.0% |
| 2022 | 7 | $123,614 | 85.7% |
| 2023 | 4 | $129,787 | 100.0% |
| 2024 | 2 | $134,092 | 50.0% |
| 2025 | 8 | $140,067 | 75.0% |
| 2026 | 4 | $242,000 | 100.0% |
| Program | Median Days | Avg Days | P25–P75 | Cases |
|---|---|---|---|---|
| H-1B | 7 | 84 | 7–7 | 19 |